Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAVORIT: Folic Acid for Vascular Outcome Reduction In Transplantation
NCT00064753Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- May 2002
- Primary completion
- Oct 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 3
01
Overview
A Phase 3 trial of folic acid in arteriosclerotic cardiovascular disease (ASCVD), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started May 2002; status: completed.
02
Drugs
folic acid
03
Conditions
arteriosclerotic cardiovascular disease (ASCVD)
Beyond the preview
Go deeper on NCT00064753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00064753.